Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117278 | SCV000151452 | likely benign | not specified | 2016-11-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000311427 | SCV000369881 | likely benign | Transient Neonatal Diabetes, Dominant/Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000338328 | SCV000369882 | likely benign | Maturity onset diabetes mellitus in young | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000885544 | SCV001028996 | benign | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001105129 | SCV001262051 | benign | Maturity-onset diabetes of the young type 10 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000885544 | SCV001946357 | benign | not provided | 2019-11-21 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002464114 | SCV002605396 | benign | Neonatal insulin-dependent diabetes mellitus | criteria provided, single submitter | research | Mutations in INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, as this mutation can cause beta cell destruction. However no sufficient evidence is found to ascertain the role of this particular variant rs41275198, yet. | |
Fulgent Genetics, |
RCV002490797 | SCV002795137 | likely benign | Type 1 diabetes mellitus 2; Maturity-onset diabetes of the young type 10; Hyperproinsulinemia; Diabetes mellitus, permanent neonatal 4 | 2021-12-22 | criteria provided, single submitter | clinical testing |